Pharmapac Holdings Limited
Registered name: PHARMAPAC HOLDINGS LIMITED
Pharmapac Holdings Limited made £23.5m revenue and a £53 loss in the year to 30 Jun 2025.
Pharmapac Holdings Limited’s revenue grew 15% to £23.5m in the year to 30 Jun 2025, with a loss of £53 and 0 employees. The company is classified under “activities of head offices” and is based in Craigavon; we hold 4 years of its filed accounts.
- Status
- Active
- Location
- Craigavon, Northern Ireland
- Age
- 18 yrs · since 2007
- Type
- Private Limited Company
Pass-through vehicle. This looks like a holding, staffing or umbrella company. Its revenue and profit may largely pass through to or from other entities, so the figures may not reflect a standalone operating business. It is excluded from our opportunity lists.
Key figures
Badges are automated estimates derived from the filed figures — not statements of fact about the company.
Financial history
| Year to | 30 Jun 2022 | 30 Jun 2023 | 30 Jun 2024 | 30 Jun 2025 |
|---|---|---|---|---|
| Disclosure | Full P&Lread from filing text | Full P&L | Full P&L | Full P&L |
| Profit & loss | ||||
| Revenue (turnover) | £19.7m | £16.5m | £20.5m | £23.5m |
| Cost of sales | £13.6m | £10.7m | £15.3m | £17.8m |
| Gross profit | £6.2m | £5.7m | £5.2m | £5.6m |
| Operating profit | £3.4m | £3.1m | £897k | £338k |
| Profit before tax | £3.3m | £2.9m | £891k | £119k |
| Profit after tax | £2.8m | £2.5m | −£53 | −£53 |
| Profit (best available) | £2.8m | £2.5m | −£53 | −£53 |
| Staff costs | — | — | £5.8m | £6.4m |
| Employees (average) | 137 | 133 | 0 | 0 |
| Ratios | ||||
| Profit margin | 14.2% | 15.4% | 0% | 0% |
| Gross margin | 31.2% | 34.8% | 25.3% | 23.9% |
| Revenue per employee | £144k | £124k | — | — |
| Profit per employee | £20.5k | £19.1k | — | — |
| Cash conversion | — | −77.8% | 128.1% | −93.4% |
| Growth (year on year) | ||||
| Revenue growth | — | ▼16.5% | ▲24.3% | ▲14.6% |
| Profit growth | — | ▼9.6% | ▼100% | — |
| Headcount growth | — | ▼2.9% | ▼100% | — |
| Balance sheet — indirect signals, not revenue | ||||
| Cash at bank | £1.1k | £1.1k | £1.1k | £1k |
| Net assets | £7.5m | £7.5m | £7.5m | £7.5m |
| Fixed assets | £7.5m | £7.5m | £7.5m | £7.5m |
| Current assets | — | £1.1k | £1.1k | £1k |
| Debtors | — | £0 | £0 | £0 |
| Deferred income | — | £0 | £0 | £0 |
| Cash from operations | — | −£2.4m | £1.1m | −£316k |
| Source | FullAccounts · bulk data Mar 2024 | FullAccounts · bulk data Mar 2024 | FullAccounts · bulk data Jun 2025 | FullAccounts · bulk data Jun 2026 |
How the business works
- Profit margin
- 0%
- Profit ÷ revenue.
- Gross margin
- 23.9%
- Gross profit ÷ revenue. High for software and services.
- Revenue per employee
- —
- Revenue ÷ average employees.
- Profit per employee
- —
- Profit ÷ average employees.
- Cash conversion
- −93.4%
- Cash generated from operations ÷ operating profit. Needs a cash-flow statement.
- Fixed assets ÷ revenue
- 32.1%
- Capital intensity. Low = capital-light, cheaper to start.
- Deferred income ÷ revenue
- 0%
- Customers paying upfront (subscriptions, deposits). Approximate when combined with accruals.
- Debtors ÷ revenue
- 0%
- Money owed by customers. Low = customers pay quickly.
Balance-sheet signals
Year-on-year changes in filed balance-sheet items. They can hint at momentum (or investment) but are not revenue or profit and must not be read as such.
- Net assets
- 0%
- Now £7.5m
- Cash at bank
- ▼5%
- Now £1k
- Headcount
- —
- Now 0
- Deferred income
- —
- Now £0
- Fixed assets
- 0%
- Now £7.5m
Deferred income is reported together with accruals in this filing (“accruals and deferred income”), so it is an approximate signal only.
Group structure
Subsidiaries (5)
- Pharmapac (U.K.) LimitedRev. £10.8m · Profit £94.7k
- Vector Consumer LimitedRev. £10.6m · Profit £33.1k
- Bapell Group LimitedFigures not disclosed
- Pharmapac Ventures LimitedFigures not disclosed
- Vector Consumer Europe LimitedFigures not disclosed
Minority corporate shareholders
- Geminae Group Limited 25–50%
- Kamell Limited 25–50%
From the Persons with Significant Control register (corporate controllers only).
Sources
Latest figures from FullAccounts for the year to 30 Jun 2025 (profit −£53), from the Companies House accounts bulk data published Jun 2026. Spotted an error? Request a correction.
Contains public sector information from Companies House licensed under the Open Government Licence v3.0. Data from Companies House, © Crown copyright. View the licence.